Suppr超能文献

胸壁 SMARCA2 缺陷但 SMARCA4 保留、形态学未分化且 Claudin-4 阴性的肿瘤。

Thoracic SMARCA2-deficient But SMARCA4-preserved Tumors With Undifferentiated Morphology Combined With Claudin-4 Negativity.

机构信息

Departments of Pathology.

Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Nagoya, Aichi Prefecture, Japan.

出版信息

Am J Surg Pathol. 2022 Jul 1;46(7):1000-1006. doi: 10.1097/PAS.0000000000001879. Epub 2022 Feb 28.

Abstract

Thoracic SMARCA4-deficient undifferentiated tumor (SMARCA4-UT) is a recently recognized tumor characterized by inactivation of SMARCA4, a SWItch/Sucrose NonFermentable chromatin remodeler, detectable by immunohistochemistry. SMARCA4-UT shows undifferentiated or rhabdoid morphology with claudin-4 negativity. However, thoracic undifferentiated tumors with the same histologic features as SMARCA4-UTs but a preserved SMARCA4 expression have so far been underrecognized. We herein report 3 cases of thoracic undifferentiated tumors with isolated loss of SMARCA2 but retained expression of SMARCA4 and SMARCB1. The present tumors were found in 2 men and 1 woman, 40 to 50 years old. All patients were heavy smokers (≥20 pack-years). The tumors were generally large masses located in the mediastinum, lung>chest wall, or lung and composed of relatively monotonous, round to epithelioid cells with variably rhabdoid cells. Immunohistochemically, the tumors showed claudin-4 negativity with variable expression of cytokeratin. All cases showed highly aggressive clinical behavior with overall survival of 2 to 10 months. These SMARCA2-deficient tumors with preserved SMARCA4 expression appeared to be clinicopathologically indistinguishable from SMARCA4-UTs, except for in their SMARCA4 status. This variant may expand the spectrum of SWItch/Sucrose NonFermentable-deficient undifferentiated tumors of the thoracic region beyond SMARCA4-UT.

摘要

胸部缺失 SMARCA4 的未分化肿瘤(SMARCA4-UT)是一种最近被认识到的肿瘤,其特征为 SMARCA4 的失活,SMARCA4 是一种 SWItch/Sucrose NonFermentable 染色质重塑剂,可通过免疫组织化学检测到。SMARCA4-UT 表现为未分化或横纹肌样形态,Claudin-4 阴性。然而,具有与 SMARCA4-UT 相同组织学特征但保留 SMARCA4 表达的胸部分化肿瘤迄今一直被低估。我们在此报告 3 例胸部分化肿瘤,其 SMARCA2 缺失但保留 SMARCA4 和 SMARCB1 的表达。目前的肿瘤发生在 2 名男性和 1 名女性,年龄在 40 至 50 岁之间。所有患者均为重度吸烟者(≥20 包年)。肿瘤通常为位于纵隔的大肿块,位于肺>胸壁或肺内,由相对单调的圆形至上皮样细胞组成,具有不同程度的横纹肌样细胞。免疫组织化学显示,肿瘤Claudin-4 阴性,细胞角蛋白表达可变。所有病例均表现出高度侵袭性的临床行为,总生存时间为 2 至 10 个月。这些保留 SMARCA4 表达的 SMARCA2 缺陷肿瘤在临床病理上似乎与 SMARCA4-UT 无法区分,除了它们的 SMARCA4 状态。这种变体可能会扩大 SWItch/Sucrose NonFermentable 缺陷性胸部分化肿瘤的范围,超出 SMARCA4-UT。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验